Genpact Limited
G
$38.34
$0.060.16%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.08B | 5.01B | 4.93B | 4.85B | 4.77B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.08B | 5.01B | 4.93B | 4.85B | 4.77B |
| Cost of Revenue | 3.25B | 3.21B | 3.17B | 3.13B | 3.08B |
| Gross Profit | 1.83B | 1.79B | 1.76B | 1.72B | 1.69B |
| SG&A Expenses | 1.05B | 1.02B | 1.00B | 979.47M | 973.41M |
| Depreciation & Amortization | 24.29M | 23.42M | 21.63M | 23.87M | 26.48M |
| Other Operating Expenses | -280.00K | -321.00K | -233.00K | -262.00K | -4.12M |
| Total Operating Expenses | 4.32B | 4.25B | 4.19B | 4.13B | 4.07B |
| Operating Income | 759.43M | 754.44M | 734.57M | 719.51M | 694.29M |
| Income Before Tax | 730.15M | 723.86M | 710.00M | 695.68M | 676.82M |
| Income Tax Expenses | 177.65M | 172.55M | 171.69M | 168.10M | 163.15M |
| Earnings from Continuing Operations | 552.49 | 551.32 | 538.30 | 527.58 | 513.67 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 552.49M | 551.32M | 538.30M | 527.58M | 513.67M |
| EBIT | 759.43M | 754.44M | 734.57M | 719.51M | 694.29M |
| EBITDA | 852.34M | 845.65M | 823.39M | 810.69M | 788.44M |
| EPS Basic | 3.18 | 3.15 | 3.06 | 2.98 | 2.88 |
| Normalized Basic EPS | 2.67 | 2.62 | 2.53 | 2.46 | 2.37 |
| EPS Diluted | 3.13 | 3.10 | 3.01 | 2.93 | 2.84 |
| Normalized Diluted EPS | 2.62 | 2.58 | 2.49 | 2.42 | 2.34 |
| Average Basic Shares Outstanding | 695.57M | 699.60M | 703.62M | 708.66M | 713.54M |
| Average Diluted Shares Outstanding | 706.59M | 710.78M | 714.39M | 718.25M | 721.75M |
| Dividend Per Share | 0.68 | 0.66 | 0.65 | 0.63 | 0.61 |
| Payout Ratio | 21.31% | 20.93% | 21.00% | 20.99% | 21.12% |